Royalty Pharma launches $200 million unsecured seven-year fixed-rate term loan via Banc of America Securities

By Paul A. Harris

St. Louis, May 5 - Royalty Pharma will host a Thursday conference call for its $200 million seven-year senior unsecured fixed-rate term loan, according to an informed source.

The deal is being marketed to high-yield accounts.

Pricing is expected early next week.

Banc of America Securities LLC is the lead arranger.

The loan comes with four years of call protection and a 101% change-of-control put.

Proceeds will be used to fund the acquisition of royalty interests.

Royalty Pharma acquires revenue-producing intellectual property - principally royalty interests in marketed and late-stage biopharmaceutical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.